Compounds > ampelopsin
Page last updated: 2024-09-04

ampelopsin and salsolinol

ampelopsin has been researched along with salsolinol in 1 studies

Compound Research Comparison

Studies
(ampelopsin)		Trials
(ampelopsin)		Recent Studies (post-2010)
(ampelopsin)		Studies
(salsolinol)		Trials
(salsolinol)		Recent Studies (post-2010) (salsolinol)
3772343284870

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Copeland, RL; Csoka, AB; Getachew, B; Manaye, KF; Tizabi, Y1

Other Studies

1 other study(ies) available for ampelopsin and salsolinol

ArticleYear
Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson's Disease.
    Neurotoxicity research, 2023, Volume: 41, Issue:2

    Topics: Cell Line, Tumor; Dopamine; Dopaminergic Neurons; gamma-Aminobutyric Acid; Humans; Neuroblastoma; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease

2023